| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -1,164.85 | -3,513.03 | 4,995.04 | -2,765.36 |
| Net Changein Cash | 983.12 | 4,661.92 | 115.48 | -1,764.78 |
| Cash Taxes Paid | 476.84 | 1,569.44 | 1,509.84 | -969.22 |
| Net Income/ Starting Line | 13,752.13 | 11,087.89 | 9,408.43 | 4,481.32 |
| Total Cash Dividends Paid | -3,613.97 | -2,898.17 | -2,518.88 | -2,158.92 |
| Changesin Working Capital | -800.43 | -506.02 | -6,604.97 | 2,569.72 |
| Cashfrom Operating Activities | 14,072.06 | 12,136.27 | 5,526.02 | 9,025.99 |
| Cash Interest Paid | 223.82 | 219.03 | 99.24 | 73.21 |
| Cashfrom Financing Activities | -7,905.82 | -6,710.16 | 2,376.07 | -5,193.46 |
| Depreciation/ Depletion | 2,575.39 | 2,556.64 | 2,529.43 | 2,143.74 |
| Other Investing Cash Flow Items Total | -3,177.58 | 1,511.61 | -5,858.10 | -4,229.70 |
| Capital Expenditures | -2,128.58 | -2,201.81 | -2,085.58 | -1,495.04 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 123.04 | -73.99 | 157.07 | 127.43 |
| Non- Cash Items | -1,455.03 | -1,002.24 | 193.13 | -168.79 |
| Financing Cash Flow Items | -3,127.00 | -298.96 | -100.09 | -269.18 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -5,306.16 | -690.20 | -7,943.68 | -5,724.74 |
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Profit Loss Sun Pharmaceutical Industries Balance Sheet Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks